Remarkably, intratumoral injection of canine ADMSC-IFN-β plus cisplatin into melanoma B16F10 cells bearing C57BL/6 mice resulted in the more prominent antitumor effects than monotherapy with ADMSC-IFN-β and cisplatin (91). The gene discussed is IFNB1; the disease is melanoma.